Antimicrobial and Antibiofilm Activity of Secondary Metabolites of Lichens against Methicillin-ResistantStaphylococcus AureusStrains from Cystic Fibrosis Patients
- 1 February 2013
- journal article
- Published by Taylor & Francis in Future Microbiology
- Vol. 8 (2) , 281-292
Abstract
Three secondary metabolites of lichens - usnic acid, atranorin and fumarprotocetraric acid - were evaluated for their in vitro antibacterial and antibiofilm activities against three strains each of methicillin-susceptible and methicillin-resistant Staphylococcus aureus (MRSA) from cystic fibrosis patients. Antibacterial activity was assessed by broth microdilution, while antibiofilm activity was evaluated by spectrophotometry or viable count. Usnic acid was significantly more active than atranorin against planktonic cells, while fumarprotocetraric acid exhibited no activity. Atranorin was the most effective in counteracting adhesion to polystyrene, although usnic acid was more active against MRSA. Usnic acid and atranorin showed comparable activity against biofilm formation, although atranorin was more active against MRSA. Usnic acid was significantly more active than atranorin against preformed biofilms. Secondary metabolites of lichens may be considered to be 'lead compounds' for the development of novel molecules for the treatment of S. aureus infections in cystic fibrosis patients.Keywords
Funding Information
- Regione Abruzzo
This publication has 45 references indexed in Scilit:
- Phenotypic and genotypic characterization of Stenotrophomonas maltophiliaisolates from patients with cystic fibrosis: Genome diversity, biofilm formation, and virulenceBMC Microbiology, 2011
- Challenges of Antibacterial DiscoveryClinical Microbiology Reviews, 2011
- Adaptation of Staphylococcus aureus to the cystic fibrosis lungInternational Journal of Medical Microbiology, 2010
- Challenging and emerging pathogens in cystic fibrosisPaediatric Respiratory Reviews, 2010
- Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistanceClinical Microbiology and Infection, 2010
- Prevalence of Community-Associated Methicillin-Resistant Staphylococcus aureus in Patients with Cystic FibrosisJournal of Clinical Microbiology, 2009
- Persistent Methicillin-resistant Staphylococcus aureus and Rate of FEV1 Decline in Cystic FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- High prevalence in cystic fibrosis patients of multiresistant hospital-acquired methicillin-resistant Staphylococcus aureus ST228-SCCmecI capable of biofilm formationJournal of Antimicrobial Chemotherapy, 2008
- Phytochemicals for Bacterial Resistance - Strengths, Weaknesses and OpportunitiesPlanta Medica, 2008
- Population Dynamics of Persistent Staphylococcus aureus Isolated from the Airways of Cystic Fibrosis Patients during a 6-Year Prospective StudyJournal of Clinical Microbiology, 2003